<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05111873</url>
  </required_header>
  <id_info>
    <org_study_id>BB004/21</org_study_id>
    <nct_id>NCT05111873</nct_id>
  </id_info>
  <brief_title>Effects of Multimodal Treatment of Headache in a Day Clinic Service</brief_title>
  <official_title>Effects of Multimodal Treatment of Headache in a Day Clinic Service: a Prospective Case-crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The observational study aims to investigate the effects of a multimodal treatment program for&#xD;
      headache patients in a day clinic service. The setting provides one week of treatment&#xD;
      including a combination of medical consultation, physiotherapy, psychological therapy,&#xD;
      occupational therapy, progressive muscle relaxation and disease specific education.&#xD;
&#xD;
      Outcome measures are the disease-specific impact on daily activities, general quality of&#xD;
      life, psychological impact and headache frequency. Moreover, the study sought to identify&#xD;
      parameters that best predict efficacy of the intervention. Therefore, standardized&#xD;
      questionnaires are established in three points in time, to evaluate the pre- and&#xD;
      post-treatment status.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      duration of treatment: 5 days; first questionnaire (V0): minimal 4 weeks prior to the&#xD;
      treatment appointment; second questionnaire (V1): on the first day of the treatment program;&#xD;
      third questionnaire (V2 / Follow up): 3 month (+- 6 weeks) after finishing the treatment;&#xD;
      data collection through patient self-report; Follow-up via mail&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Veterans RAND 12 Item Health Survey (VR-12) mental health score</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Depression Anxiety and Stress Scale (DASS)</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>questionnaire, patient self-report, 21 questions, 7 questions per subscale (Depression, Anxiety and Stress), minimum value: 0 points, maximum value: 21 points per subscale, higher score = worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Headache Impact Test (HIT6)</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>questionnaire, patient self-report, minimum value: 36 points, maximum value: 78 points, higher score = worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Pain intensity</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>average pain intensity in the last month, scale 1 to 10, higher score = worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Headache frequency</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>in days per month, referring to the last month, minimum value: 0 days/month, maximum value: 30 days/month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Veterans RAND 12 Item Health Survey (VR-12) physical health score</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of Veterans RAND 12 Item Health Survey (VR-12) single domains</measure>
    <time_frame>4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatment</time_frame>
    <description>questionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Headache Disorders</condition>
  <arm_group>
    <arm_group_label>waiting-list control</arm_group_label>
    <description>Participants enquired prior to the treatment appointment in the neurological day clinic service, no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>post-treatment group</arm_group_label>
    <description>Participants enquired after the treatment in the Neurological day clinic service</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>multimodal treatment</intervention_name>
    <description>combination of medical consultations, psychological therapy, physiotherapy, occupational therapy, disease specific education und progressive muscle relaxation</description>
    <arm_group_label>post-treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients seen in the neurological day clinic service will be screened for eligibility.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of a headache disorder&#xD;
&#xD;
          -  written informed consent for collecting and analysing data and conducting a follow-up&#xD;
             evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  premature interruption of the treatment&#xD;
&#xD;
          -  repeated treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robert Fleischmann, MD</last_name>
    <phone>+493834866778</phone>
    <email>robert.fleischmann@uni-greifswald.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology</name>
      <address>
        <city>Greifswald</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Fleischmann, MD</last_name>
      <phone>+49-3834 86-6855</phone>
      <email>robert.fleischmann@uni-greifswald.de</email>
    </contact>
    <investigator>
      <last_name>Robert Fleischmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nadja Fiebig</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>multimodal treatment</keyword>
  <keyword>quality of life</keyword>
  <keyword>day clinic service</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

